{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T01:33:00Z","timestamp":1775093580044,"version":"3.50.1"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Cardiac contractility modulation (CCM) is a novel device-based therapy in patients with heart failure with reduced ejection fraction (HFrEF). In randomized clinical trials and real-life studies, CCM has been shown to improve exercise tolerance and quality of life, reverse left ventricular remodeling and reduce hospitalization in patients with HFrEF. In this case report, we describe for the first time the use of CCM as a \u201cbridge to transplant\u201d in a young obese patient with advanced heart failure due to non-ischemic dilated cardiomyopathy. The patient had a poor quality of life and frequent heart failure-related hospitalizations despite the optimal medical therapy and, due to obesity, a suitable heart donor was unlikely to be identified in the short term and due to severe obesity risk of complications after implantation of a left ventricular assist device (LVAD) was very high.<\/jats:p>","DOI":"10.3389\/fcvm.2022.833143","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T07:14:37Z","timestamp":1644995677000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Use of Cardiac Contractility Modulation as Bridge to Transplant in an Obese Patient With Advanced Heart Failure: A Case Report"],"prefix":"10.3389","volume":"9","author":[{"given":"Daniele","family":"Masarone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Petraio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santo","family":"Dellegrottaglie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Ammendola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo","family":"Nigro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Pacileo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1016\/S0140-6736(17)31071-1","article-title":"Heart failure","volume":"390","author":"Metra","year":"2017","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jchf.2020.01.014","article-title":"Advanced heart failure: epidemiology, diagnosis, and therapeutic approaches","volume":"8","author":"Truby","year":"2020","journal-title":"JACC Heart Fail."},{"key":"B3","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jchf.2021.05.009","article-title":"Advanced heart failure epidemiology and outcomes: a population-based study","volume":"9","author":"Dunlay","year":"2021","journal-title":"JACC Heart Fail."},{"key":"B4","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.cardfail.2019.03.007","article-title":"Nutrition, obesity, and cachexia in patients with heart failure: a consensus statement from the Heart Failure Society of America Scientific Statements Committee","volume":"25","author":"Vest","year":"2019","journal-title":"J Card Fail."},{"key":"B5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/SLA.0b013e3181b5db3c","article-title":"The effect of body mass index on survival following heart transplantation: do outcomes support consensus guidelines?","volume":"251","author":"Russo","year":"2010","journal-title":"Ann Surg."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.healun.2015.10.023","article-title":"The 2016 international society for heart lung transplantation listing criteria for heart transplantation: a 10-year update","volume":"35","author":"Mehra","year":"2016","journal-title":"J Heart Lung Transplant."},{"key":"B7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11897-020-00500-z","article-title":"Clinical outcomes, trends in weight, and weight loss strategies in patients with obesity after durable ventricular assist device implantation","volume":"18","author":"Gadela","year":"2021","journal-title":"Curr Heart Fail Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.hfc.2021.05.005","article-title":"Cardiac resynchronization therapy and cardiac contractility modulation in patients with advanced heart failure: how to select the right candidate?","volume":"17","author":"Abraham","year":"2021","journal-title":"Heart Fail Clin."},{"key":"B9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejheart.2005.05.011","article-title":"Cardiac contractility modulation by non-excitatory currents: studies in isolated cardiac muscle","volume":"8","author":"Brunckhorst","year":"2006","journal-title":"Eur J Heart Fail."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1152\/ajpheart.00378.2002","article-title":"Electric currents applied during refractory period enhance contractility and systolic calcium in the ferret heart","volume":"284","author":"Mohri","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e006512","DOI":"10.1161\/CIRCHEARTFAILURE.119.006512","article-title":"Safety, performance, and efficacy of cardiac contractility modulation delivered by the 2-lead optimizer smart system: the FIX-HF-5C2 study","volume":"13","author":"Wiegn","year":"2020","journal-title":"Circ Heart Fail"},{"key":"B12","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.jchf.2018.04.010","article-title":"A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation","volume":"6","author":"Abraham","year":"2018","journal-title":"JACC Heart Fail."},{"key":"B13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ijcard.2016.02.001","article-title":"Long-term survival with cardiac contractility modulation in patients with NYHA II or III symptoms and normal QRS duration","volume":"209","author":"Kloppe","year":"2016","journal-title":"Int J Cardiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ijcard.2014.12.178","article-title":"Efficacy and survival in patients with cardiac contractility modulation: long-term single center experience in 81 patients","volume":"183","author":"Kuschyk","year":"2015","journal-title":"Int J Cardiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/ejhf.2202","article-title":"Long-term clinical experience with cardiac contractility modulation therapy delivered by the optimizer smart system","volume":"23","author":"Kuschyk","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"B16","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.hfc.2021.05.006","article-title":"Mitral and tricuspid valves percutaneous repair in patients with advanced heart failure: panacea, or Pandora's box?","volume":"17","author":"Cammalleri","year":"2021","journal-title":"Heart Fail Clin"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.healun.2020.09.005","article-title":"MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry","volume":"39","author":"Godino","year":"2020","journal-title":"J Heart Lung Transplant."},{"key":"B18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ejhf.2333","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"24","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.hfc.2021.05.004","article-title":"Inotropes in patients with advanced heart failure: not only palliative care","volume":"17","author":"Masarone","year":"2021","journal-title":"Heart Fail Clin."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1097\/FJC.0000000000001163","article-title":"Hemodynamic Effects of Levosimendan in outpatients with advanced heart failure: an echocardiographic pilot study","volume":"79","author":"Masarone","year":"2022","journal-title":"J Cardiovasc Pharmacol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"919","DOI":"10.2459\/JCM.0000000000000983","article-title":"Efficacy and safety of repeated infusion of levosimendan in outpatients with advanced heart failure: a real-world experience","volume":"21","author":"Masarone","year":"2020","journal-title":"J Cardiovasc Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ehjcr\/ytaa205","article-title":"It is easy to see, but it is better to foresee: a case report on the favourable alliance between CardioMEMS and levosimendan","volume":"34","author":"Visco","year":"2020","journal-title":"Eur Heart J Case Rep."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.833143\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T07:14:41Z","timestamp":1644995681000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.833143\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,16]]},"references-count":22,"alternative-id":["10.3389\/fcvm.2022.833143"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.833143","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,16]]},"article-number":"833143"}}